Table 2.

Estimates of the incident cases of CPA in India, and associated mortality.

Sub-groups	Sub-group population estimate	CPA	Assumptions for CPA cases and deaths
PTB cases and CPA from (mis)diagnosis and during therapy (steps 1and2)
HIV+, clinically diagnosed	19 320	1 932	10%
HIV−, clinically diagnosed	933800	176 422	19%
HIV+, proven PTB	22 680	1 588	7%
HIV−, proven PTB	1 096200	32 828	3%
Total CPA cases		3 213 828
Deaths from CPA during and immediately after therapy for PTB (step 3)
HIV+		704	20% CPA mortality over the 12 months after PTB diagnosis
HIV−		42 062	20% CPA mortality over the 12 months after PTB diagnosis
Total CPA deaths in 12 months from PTB diagnosis		42 766
PTB cases and new CPA diagnoses 6–12 months after PTB diagnosis (step 4)
HIV+	30 380	3 038	10%
HIV−	1 467 350	146 735	10%
Total		149 774
Diagnosed CPA patients in 12 months after PTB diagnosis, including CPA deaths (steps 1,2,3and4)
HIV+		6 558
HIV−		357 043
Total		363 601
New CPA cases each year, arising 2–5 years after PTB therapy from this annual cohort of PTB cases (step 5)
HIV+, with cavitation	6 016	391	6.5%
HIV+, without cavitation	21 109	43	0.2%
HIV−, with cavitation		18 885	6.5%
HIV−, without cavitation	1 030 082		0.2%
Total		21 379